InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Dorval Allison, Director. Director active across 2 companies, notably Puma Biotechnology, INC.. Aggregated, 10 filings have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €67k. Activity tracked since 14 June 2022. The latest transaction was filed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
10 of 10 declarations
Allison Dorval is a Board Member at Puma Biotechnology, Inc. She plays a key role in the governance of the company, bringing her expertise and experience in the biopharmaceutical sector. As a board member, she is involved in overseeing Puma Biotechnology's activities and making strategic decisions that influence its future. Her commitment to compliance and performance is essential for the company.